Syncapone 150 MG (Levodopa/Carbidopa/Entacapone)

Syncapone 150 mg is a powerful combination tablet used to manage Parkinson’s disease. It contains three active ingredients: Levodopa, which converts to dopamine in the brain to improve movement; Carbidopa, which helps prevent Levodopa from breaking down before it reaches the brain; and Entacapone, a COMT inhibitor that extends the effect of Levodopa. Together, these ingredients offer a more stable and long-lasting control of Parkinsonian symptoms.

This medication is especially helpful for patients experiencing “wearing-off” symptoms between doses of Levodopa. Syncapone helps maintain consistent dopamine levels in the brain, improving symptoms such as tremors, rigidity, slowness, and muscle stiffness. It should be taken exactly as prescribed, usually with meals, and not discontinued abruptly. Syncapone simplifies Parkinson’s treatment by combining three essential medications into a single tablet, improving both treatment adherence and quality of life. Regular use supports better motor control and smoother day-to-day function for individuals with advanced Parkinson’s disease.